These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26858951)

  • 1. Breast Cancer Genetic Counseling: A Surgeon's Perspective.
    Agnese DM; Pollock RE
    Front Surg; 2016; 3():4. PubMed ID: 26858951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical aspects of delivering hereditary cancer risk counseling.
    DeMarco TA; Smith KL; Nusbaum RH; Peshkin BN; Schwartz MD; Isaacs C
    Semin Oncol; 2007 Oct; 34(5):369-78. PubMed ID: 17920890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
    Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
    J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new paradigm of genetic testing for hereditary breast/ovarian cancers.
    Kwong A; Chen JW; Shin VY
    Hong Kong Med J; 2016 Apr; 22(2):171-7. PubMed ID: 26980575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION SUMMARY, Number 793.
    Obstet Gynecol; 2019 Dec; 134(6):1366-1367. PubMed ID: 31764755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations in genetic counseling for inherited breast cancer predisposition.
    Robson ME; Offit K
    Semin Radiat Oncol; 2002 Oct; 12(4):362-70. PubMed ID: 12382194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary breast-ovarian cancer at the bedside: role of the medical oncologist.
    Lynch HT; Snyder CL; Lynch JF; Riley BD; Rubinstein WS
    J Clin Oncol; 2003 Feb; 21(4):740-53. PubMed ID: 12586815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The breast surgeon's role in BRCA1 and BRCA2 testing.
    Matloff ET
    Am J Surg; 2000 Oct; 180(4):294-8. PubMed ID: 11113439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond easy answers: the plastic surgeon and prenatal diagnosis.
    Matthews MS
    Cleft Palate Craniofac J; 2002 Mar; 39(2):179-82. PubMed ID: 11879075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary breast cancer: practical pursuit for clinical translation.
    Lynch HT; Snyder C; Lynch J
    Ann Surg Oncol; 2012 Jun; 19(6):1723-31. PubMed ID: 22434244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
    Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H
    JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond BRCA1 and BRCA2.
    King-Spohn K; Pilarski R
    Curr Probl Cancer; 2014; 38(6):235-48. PubMed ID: 25497410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On using a cancer center cancer registry to identify newly affected women eligible for hereditary breast cancer syndrome testing: practical considerations.
    DeMarco TA; Loffredo CA; Sampilo ML; Tercyak KP
    J Genet Couns; 2006 Apr; 15(2):129-36. PubMed ID: 16761104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can breast surgeons provide breast cancer genetic testing? An American Society of Breast Surgeons survey.
    Beitsch PD; Whitworth PW
    Ann Surg Oncol; 2014 Dec; 21(13):4104-8. PubMed ID: 24756810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning.
    Koehly LM; Peterson SK; Watts BG; Kempf KK; Vernon SW; Gritz ER
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):304-13. PubMed ID: 12692104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.
    Menko FH; Ter Stege JA; van der Kolk LE; Jeanson KN; Schats W; Moha DA; Bleiker EMA
    Fam Cancer; 2019 Jan; 18(1):127-135. PubMed ID: 29846880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer risk assessment and the genetic counseling process: using hereditary breast and ovarian cancer as an example.
    Prucka SK; McIlvried DE; Korf BR
    Med Princ Pract; 2008; 17(3):173-89. PubMed ID: 18408385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.